Fig. 3.
Fig. 3. Cross blocking of anti-vWf monoclonal antibodies. / Binding of 125I-labeled monoclonal antibodies (final concentration, 1 μg/mL) to immobilized native vWf (A-D) or 39/34-kd vWf fragment (E-F) in 30 minutes at 22°C. Unlabeled antibodies were at a final concentration of 100 μg/mL. Specific binding in the presence of blocking antibodies was expressed as a percentage of maximal specific binding measured in the absence of blocking antibody. Panel, monoclonal antibody: A, 2C9; B, 5D2; C, 6G1; D, CR1; E, 6G1; F, CR11. Results are the mean of triplicate determinations, with standard deviation from the mean of ≤ 5%.

Cross blocking of anti-vWf monoclonal antibodies.

Binding of 125I-labeled monoclonal antibodies (final concentration, 1 μg/mL) to immobilized native vWf (A-D) or 39/34-kd vWf fragment (E-F) in 30 minutes at 22°C. Unlabeled antibodies were at a final concentration of 100 μg/mL. Specific binding in the presence of blocking antibodies was expressed as a percentage of maximal specific binding measured in the absence of blocking antibody. Panel, monoclonal antibody: A, 2C9; B, 5D2; C, 6G1; D, CR1; E, 6G1; F, CR11. Results are the mean of triplicate determinations, with standard deviation from the mean of ≤ 5%.

Close Modal

or Create an Account

Close Modal
Close Modal